1-1 of 1
Rui Murahashi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma

Clinical Trials & Observations
Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, Kaoru Sekiguchi, Yuta Fukui, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kento Umino, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Masahiro Ashizawa, Masuzu Ueda, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-ichiro Fujiwara, Yoshinobu Kanda
Journal: Blood
Blood (2022) 140 (6): 594–607.
https://doi.org/10.1182/blood.2021015220
Published: 2022
Includes: Supplemental data